Innocan Pharma Corp. Stock
We can see a decrease in the price for Innocan Pharma Corp.. Compared to yesterday it has lost -€0.003 (-1.240%).
Currently there is a rather positive sentiment for Innocan Pharma Corp. with 5 Buy predictions and 0 Sell predictions.
With a target price of 1 € there is potential for a 403.78% increase which would mean more than doubling the current price of 0.2 € for Innocan Pharma Corp..
Our community identified positive and negative aspects for Innocan Pharma Corp. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Innocan Pharma Corp. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Innocan Pharma Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
Herzliya, Israel and Calgary, Alberta - May 09, 2024 - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
With its submission of a Pre-IND Meeting Request Letter, Innocan initiates the regulatory process with the U.S. Food and Drug Administration (FDA) for the approval of its prolonged CBD
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M
Herzliya, Israel and Calgary, Alberta – April 1, 2024 – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the “Company” or “Innocan”), a pharmaceutical technology company